Viatris Reports - Industry Research

Active Pharmaceutical Ingredients (API) Market

The Active Pharmaceutical Ingredients Market size is estimated at USD 216.5 billion in 2024, and is expected to reach USD 306.90 billion by 2029, growing at a CAGR of 7.22% during the forecast period (2024-2029).

Transdermal Skin Patches Market

The Transdermal Skin Patches Market size is estimated at USD 8.92 billion in 2024, and is expected to reach USD 11.33 billion by 2029, growing at a CAGR of 4.87% during the forecast period (2024-2029).

Over-the-counter (OTC) Analgesics Market

The Over-the-counter Analgesics Market size is estimated at USD 29.83 billion in 2024, and is expected to reach USD 35.97 billion by 2029, growing at a CAGR of 3.81% during the forecast period (2024-2029).

Systemic Lupus Erythematosus Market

The systemic lupus erythematosus market is poised to grow at a CAGR of 7.1% during the forecast period.

Global Loratadine Market

The loratadine market is expected to record a CAGR of 2% over the forecast period (2022-2027).

Global Vertigo Treatment Market

The vertigo treatment market is expected to grow at a registered CAGR of 5.5% during the forecast period.

Europe Anesthesia Drugs Market

The Europe Anesthesia Drugs Market size is estimated at USD 1.81 billion in 2024, and is expected to reach USD 2.10 billion by 2029, growing at a CAGR of 3.17% during the forecast period (2024-2029).

Thyroid Gland Disorders Treatment Market

The thyroid gland disorders treatment market is projected to register a CAGR of 3.5% during the forecast period.

Tourette Syndrome Treatment Market

The tourette syndrome (TS) treatment market is expected to register a CAGR of 10.4% over the forecast period.

Pregabalin Market

The pregabalin market is projected toregister a CAGR of nearly 3% over the forecast period.

Pelvic Inflammatory Disease Therapeutics Market

The pelvic inflammatory disease therapeutics market studied was anticipated to witness a CAGR of 5.6% during the forecast period.

Global Myeloproliferative Disorders (MPD) Treatment Market

The myeloproliferative disorders (MPD) treatment market is expected to register a CAGR of 4.9% over the forecast period.

Fondaparinux Market

The fondaparinux market is expected to register a CAGR of 6.2% over the forecast period.

Global Hyperlipidemia Drugs Market

The hyperlipidemia drugs market is expected to register a CAGR of 2.3% during the forecast period.

Global Sepsis Therapeutics Market

The sepsis therapeutics market is projected to register a CAGR of 7.6% over the forecast period.

Sulphonamides Market

The sulphonamides market is anticipated to record a CAGR of nearly 4.1% over the forecast period.

Esomeprazole Market

The Esomeprazole Market is expected to register a CAGR of 5.2% over the forecast period.

Global Herpes Zoster Infection Treatment Market

During the time frame of the forecast, the herpes zoster infection treatment market is expected to register a CAGR of 4.1%.

United Kingdom Drug Delivery Devices Market

• The United Kingdom's drug delivery devices market is anticipated to register a CAGR of 22.81% during the forecast period.

Europe, MEA Substance Abuse Treatment Market

The Europe, Middle East, and Africa substance abuse treatment market is expected to witness a CAGR of 9.0% over the forecast period.

Osteonecrosis Treatment Market

The osteonecrosis treatment market is expected to register a CAGR of 6.2% during the forecast period.

Vulvodynia Treatment Market

The vulvodynia treatment market is expected to register a CAGR of nearly 9% over the forecast period.

Italy Drug Delivery Devices Market

The Italian drug delivery devices market is expected to register a CAGR of 22.4% over the forecast period.

Candidiasis Therapeutics Market

The candidiasis therapeutics market is expected to register a CAGR of 5.1% over the forecast period.

Hospital Infection Therapeutics Market

The hospital infection therapeutics market is expected to register a CAGR of 7.2% over the forecast period.

Peripheral Neuritis Treatment Market

The peripheral neuritis treatment market is expected to register a CAGR of 3.3% during the forecast period.

Prophylactic HIV Drugs Market

The prophylactic human immunodeficiency virus (HIV) drug market is expected to register a CAGR of 4.1% during the forecast period.

Pneumonia Treatment Market

The pneumonia treatment market is expected to register a CAGR of 8.2% during the forecast period.

Granisetron Market

The granisetron market is expected to register a CAGR of 6.2 % over the forecast period.

Global Argatroban Market

The argatroban market is expected to register a CAGR of 3.5% over the forecast period, 2022-2027.

United States Active Pharmaceutical Ingredients (API) Market

The United States Active Pharmaceutical Ingredients (API) market is expected to register a CAGR of 9.5% over the forecast period.

United Kingdom Active Pharmaceutical Ingredients (API) Market

The United Kingdom Active Pharmaceutical Ingredients (API) market is expected to register a CAGR of 6.3% over the forecast period.

France Active Pharmaceutical Ingredients (API) Market

The French Active Pharmaceutical Ingredients (API) market is expected to register a CAGR of 6.1% over the forecast period.

India Active Pharmaceutical Ingredients (API) Market

The India Active Pharmaceutical Ingredients Market size is estimated at USD 13.64 billion in 2024, and is expected to reach USD 20.32 billion by 2029, growing at a CAGR of 8.31% during the forecast period (2024-2029).

Saudi Arabia Active Pharmaceutical Ingredients (API) Market

The Saudi Arabian Active Pharmaceutical Ingredients (API) market is expected to register a CAGR of 2% over the forecast period.